Examkin

Question

Difficulty: Very hardPreventive Care and Screening

A 26-year-old female presents to the clinic for a routine wellness and preconception counseling visit. She and her partner plan to start trying to conceive in the next 3 months. Her medical history is significant for severe Crohn's disease, which has been in clinical and endoscopic remission for the past two years on maintenance therapy with infliximab. She has no other medical conditions and takes a daily prenatal vitamin. She recalls never having chickenpox as a child, and a recent occupational health laboratory screening showed negative varicella-zoster virus (VZV) IgG antibodies. Her only previous cervical cancer screening was a normal Pap smear (cervical cytology) at age 23. She received a Tdap booster 2 years ago and an inactivated influenza vaccine 1 month ago. Vital signs and physical examination are unremarkable. Which of the following is the most appropriate next step in her preventive care?

  1. A
    Administer the live-attenuated varicella vaccine, perform cervical cytology alone, and advise delaying conception for 4 weeks.
  2. B
    Perform cervical cytology with high-risk HPV co-testing, administer the recombinant zoster vaccine, and continue infliximab.
  3. Perform cervical cytology alone, advise that the varicella vaccine is currently contraindicated, and counsel on strict avoidance of varicella exposures.Answer
  4. D
    Temporarily withhold infliximab for 2 weeks, administer the live-attenuated varicella vaccine, and perform cervical cytology alone.
  5. E
    Administer varicella-zoster immune globulin (VZIG) today, perform cervical cytology alone, and advise proceeding with conception.

Answer

The correct intervention is to perform cervical cytology alone, advise that the varicella vaccine is contraindicated due to her immunosuppressive therapy, and counsel her to strictly avoid varicella exposures.
The correct answer accurately synthesizes two critical guidelines. First, the USPSTF recommends cervical cytology alone every 3 years for women aged 21-29; at age 26, exactly 3 years from her last normal test, she is due. Second, although she lacks immunity to varicella (a high-risk scenario for planned pregnancy), the varicella vaccine is live-attenuated and is absolutely contraindicated while she is taking a TNF-alpha inhibitor (infliximab). Therefore, primary prevention through strict exposure avoidance is the safest and only guideline-concordant strategy.

Step-by-Step Solution

1
Evaluate the patient's cervical cancer screening needs based on age and previous screening history.
The patient is 26 years old. According to USPSTF guidelines, women aged 21 to 29 should undergo cervical cytology (Pap smear) alone every 3 years. Since her last cytology was at age 23, she is currently due.
Age-specific guidelines restrict HPV co-testing to women aged 30 and older to avoid over-treating transient HPV infections common in younger women.
2
Assess the patient's varicella immunity and the necessity of vaccination prior to conception.
The patient has no clinical history of chickenpox and her VZV IgG is negative, indicating she is susceptible to primary varicella, which poses severe maternal and fetal risks during pregnancy.
Identifying susceptible women before pregnancy is a critical component of preconception counseling.
3
Check for absolute pharmacologic contraindications to the indicated preventive interventions.
The varicella vaccine is a live-attenuated virus. The patient is on infliximab, a TNF-alpha inhibitor that causes systemic immunosuppression.
Live vaccines are absolutely contraindicated in patients on biologic therapies due to the risk of uncontrolled, disseminated vaccine-strain viral infection.
4
Synthesize the findings to determine the safest and most appropriate management plan.
The patient must receive cervical cytology alone. She cannot safely receive the varicella vaccine, nor can she safely stop her biologic medication without risking a severe disease flare prior to pregnancy. Therefore, counseling on strict avoidance of varicella exposures is the only safe option for VZV prevention.
Balancing the timing of screenings, maternal safety, and pharmacologic contraindications dictates this conservative approach.

Key Concept

Live-attenuated vaccines (e.g., varicella, MMR) are absolutely contraindicated in patients receiving biologic immunosuppressants (e.g., TNF-alpha inhibitors). For women aged 21-29, routine cervical cancer screening consists of cervical cytology alone every 3 years, without HPV co-testing.
Estimated Time:2m 0s
Rate this question

Topics

Preventive Care and Screening

More questions from this topic